These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29053703)

  • 1. Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds.
    Berkhout DJC; Niemarkt HJ; Benninga MA; Budding AE; van Kaam AH; Kramer BW; Pantophlet CM; van Weissenbruch MM; de Boer NKH; de Meij TGJ
    Pediatr Res; 2018 Feb; 83(2):412-419. PubMed ID: 29053703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Sepsis in Preterm Infants by Fecal Volatile Organic Compounds Analysis: A Proof of Principle Study.
    Berkhout DJC; Niemarkt HJ; Buijck M; van Weissenbruch MM; Brinkman P; Benninga MA; van Kaam AH; Kramer BW; Andriessen P; de Boer NKH; de Meij TGJ
    J Pediatr Gastroenterol Nutr; 2017 Sep; 65(3):e47-e52. PubMed ID: 27846067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Volatile Organic Compounds in Preterm Infants Are Influenced by Enteral Feeding Composition.
    El Manouni El Hassani S; Niemarkt HJ; Said H; Berkhout DJC; van Kaam AH; van Lingen RA; Benninga MA; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2018 Sep; 18(9):. PubMed ID: 30208643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Detection of Necrotizing Enterocolitis by Fecal Volatile Organic Compounds Analysis.
    de Meij TG; van der Schee MP; Berkhout DJ; van de Velde ME; Jansen AE; Kramer BW; van Weissenbruch MM; van Kaam AH; Andriessen P; van Goudoever JB; Niemarkt HJ; de Boer NK
    J Pediatr; 2015 Sep; 167(3):562-7.e1. PubMed ID: 26188801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late-onset Sepsis in Preterm Infants Can Be Detected Preclinically by Fecal Volatile Organic Compound Analysis: A Prospective, Multicenter Cohort Study.
    Berkhout DJC; van Keulen BJ; Niemarkt HJ; Bessem JR; de Boode WP; Cossey V; Hoogenes N; Hulzebos CV; Klaver E; Andriessen P; van Kaam AH; Kramer BW; van Lingen RA; Schouten A; van Goudoever JB; Vijlbrief DC; van Weissenbruch MM; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ
    Clin Infect Dis; 2019 Jan; 68(1):70-77. PubMed ID: 29931245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Detection of Non-catheter Related Late-onset Sepsis in Preterm Infants by Fecal Volatile Compounds Analysis: A Prospective, Multi-center Cohort Study.
    Berkhout DJC; Niemarkt HJ; Andriessen P; Vijlbrief DC; Bomers MK; Cossey V; Hulzebos CV; van Kaam AH; Kramer BW; van Lingen RA; Wicaksono AN; Covington JA; van Weissenbruch MM; Benninga MA; de Boer NKH; de Meij TGJ
    Pediatr Infect Dis J; 2020 Apr; 39(4):330-335. PubMed ID: 32032172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal Volatile Organic Compound Profiles are Not Influenced by Gestational Age and Mode of Delivery: A Longitudinal Multicenter Cohort Study.
    Deianova N; El Manouni El Hassani S; Niemarkt HJ; Cossey V; van Kaam AH; Jenken F; van Weissenbruch MM; Doedes EM; Baelde K; Menezes R; Benninga MA; de Jonge WJ; de Boer NK; de Meij TG
    Biosensors (Basel); 2020 May; 10(5):. PubMed ID: 32403393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of gut microbiota and fecal volatile organic compounds analysis as early diagnostic biomarker for necrotizing enterocolitis and sepsis in preterm infants.
    Berkhout DJC; Niemarkt HJ; de Boer NKH; Benninga MA; de Meij TGJ
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):457-470. PubMed ID: 29488419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled Volatile Organic Compounds for Early Prediction of Bronchopulmonary Dysplasia in Infants Born Preterm.
    Romijn M; van Kaam AH; Fenn D; Bos LD; van den Akker CHP; Finken MJJ; Rotteveel J; Cerullo J; Brinkman P; Onland W
    J Pediatr; 2023 Jun; 257():113368. PubMed ID: 36868304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Potential of Fecal Volatile Organic Compound Analysis for the Early Diagnosis of Late-Onset Sepsis in Preterm Infants: A Narrative Review.
    de Kroon RR; Frerichs NM; Struys EA; de Boer NK; de Meij TGJ; Niemarkt HJ
    Sensors (Basel); 2024 May; 24(10):. PubMed ID: 38794014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Gut Microbiota Changes in Preterm Infants with Bronchopulmonary Dysplasia: A Pilot Case-Control Study.
    Chen SM; Lin CP; Jan MS
    Am J Perinatol; 2021 Sep; 38(11):1142-1149. PubMed ID: 32446254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Assessment of Fecal Volatile Organic Compounds in Healthy Infants: Electronic Nose Device Predicts Patient Demographics and Microbial Enterotype.
    Hosfield BD; Pecoraro AR; Baxter NT; Hawkins TB; Markel TA
    J Surg Res; 2020 Oct; 254():340-347. PubMed ID: 32526503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose.
    Bosch S; Lemmen JP; Menezes R; van der Hulst R; Kuijvenhoven J; Stokkers PC; de Meij TG; de Boer NK
    J Breath Res; 2019 Jun; 13(4):046001. PubMed ID: 31170704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the level of urinary cysteinyl leukotriene E4 in diagnosis of bronchopulmonary dysplasia in premature infants].
    Jin R; Lu HY; Luo YY; Xu YX; Hu YH; Chen XQ
    Zhonghua Er Ke Za Zhi; 2016 Sep; 54(9):703-7. PubMed ID: 27596087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive values of plasma KL-6 in bronchopulmonary dysplasia in preterm infants.
    Dilli D; Özyazici A; Dursun A; Beken S
    Turk J Med Sci; 2017 Apr; 47(2):621-626. PubMed ID: 28425256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early inhaled nitric oxide in preterm infants <34 weeks with evolving bronchopulmonary dysplasia.
    Jiang Q; Gao X; Liu C; Chen D; Lin X; Xia S; Zhuang D; Yang C; Zhu W; Liu L; Chen C; Sun B
    J Perinatol; 2016 Oct; 36(10):883-9. PubMed ID: 27442155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of volatile organic compounds as a diagnostic tool in preterm infants.
    Wright H; Bannaga AS; Iriarte R; Mahmoud M; Arasaradnam RP
    Pediatr Res; 2021 Jan; 89(2):263-268. PubMed ID: 32120380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The assessment of microbiome changes and fecal volatile organic compounds during experimental necrotizing enterocolitis.
    Hosfield BD; Drucker NA; Pecoraro AR; Shelley WC; Li H; Baxter NT; Hawkins TB; Markel TA
    J Pediatr Surg; 2021 Jun; 56(6):1220-1225. PubMed ID: 33745738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Microbiome of the Lower Respiratory Tract in Premature Infants with and without Severe Bronchopulmonary Dysplasia.
    Imamura T; Sato M; Go H; Ogasawara K; Kanai Y; Maeda H; Chishiki M; Shimizu H; Mashiyama F; Goto A; Momoi N; Hosoya M
    Am J Perinatol; 2017 Jan; 34(1):80-87. PubMed ID: 27240094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.